Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells

BACKGROUND: Epigallocatechin-3-gallate (EGCG) has exhibited antitumor properties in several types of cancers, including nasopharyngeal carcinoma (NPC), but the molecular mechanisms underlying this function remain incompletely understood. The aim of the present study was to characterize the global im...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bin-Bin, Huang, Guo-Liang, Li, Hua-Hui, Kong, Xia, He, Zhi-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221119/
https://www.ncbi.nlm.nih.gov/pubmed/28051030
http://dx.doi.org/10.4103/0366-6999.196586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221119/
https://www.ncbi.nlm.nih.gov/pubmed/28051030
http://dx.doi.org/10.4103/0366-6999.196586

Ejemplares similares